Zoetis Receives EU Approval for New Vaccine
Zoetis announced that the European Commission, or EC, has granted marketing authorization for Poulvac Procerta HVT-ND, a recombinant vector vaccine for the protection of chickens against Newcastle disease, or ND, and Marek's disease viruses. The vaccine provides protection against both diseases with a single dose. Newcastle disease is a notifiable disease under EU animal health regulations and a significant cause of mortality and production losses in commercial poultry. Two other vaccines have received European Commission marketing authorization. Poulvac Procerta HVT-IBD, the first in the range to receive this authorization, protects against infectious bursal disease and Marek's disease. Poulvac Procerta HVT-IBD-ND, authorized in 2025, protects against Newcastle disease, infectious bursal disease, and Marek's disease in a single dose.
